MRC1 and cancer: The cancer spectrum is related to the nature of the MMR gene mutated; patients with MSH6 and/or PMS2 mutations develop brain tumours within 10 years of life and over 40% of patients homozygous for PMS2 mutations develop second primary malignancies [29].